US Patent Issued to Massachusetts Institute of Technology on Sept. 22 for "Selective MCL-1 binding peptides" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,997, issued on Sept. 22, was assigned to Massachusetts Institute of Technology (Cambridge, Mass.).

"Selective MCL-1 binding peptides" was invented by Raheleh Rezaei-Araghi (Brookline, Mass.) and Amy E. Keating (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are peptides that bind Mcl-1. Also provided are compositions containing these polypeptides and methods of using such peptides in the treatment of cancer that include administering to a subject one of the polypeptides."

The patent was filed on April 3, 2023, under Application No. 18/295,214.

*For further information, including images, charts and tables, please v...